Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin

• Status: Completed
• Trial end date: 2006-04-01
• Target enrollment: 0
• Participant gender: All

Summary

Trial of new insulin injection pen called Pre-filled Pen B by type 2 diabetics in take home situations. Patients must use insulin lispro injection [rDNA origin] Low Mix twice daily during the trial.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Insulin; Insulin Lispro; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Type 2 Diabetes

• Already on Lilly insulin or beginning insulin therapy

• 25 to 75 years old inclusive

Exclusion Criteria:

• Currently using, or had used during previous month, oral diabetes medication that is NOT approved for use in combination with insulin in patient's country

• More than 3 unexplained episodes of severe hypoglycemia within 6 months prior to trial